Bone Modifying Agents in Cancer Treatment

Exploring the significance of bone modifying agents in breast, prostate, and hematologic malignancies, as well as their role in managing bone metastases and rare bone sarcomas. Emphasis on baseline bone density scans, dental evaluations, monitoring for side effects, and therapy duration considerations.